Eledon Pharmaceuticals, Inc. (ELDN) stock forecast and price target
Price $2.12 · data as of November 13, 2026
12-month price target
Average target$9.00
Upside / downside+325.5%
Analysts5
ConsensusStrong buy
Low $7.00Average $9.00High $12.00
Gold marker: average target · white marker: today’s price ($2.12)
Analyst ratings
Strong buy 0Buy 6Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.89 | −71.2% | $0 |
| Next fiscal year ends December 31, 2027 | $-0.76 | +14.2% | $0 |
| Next quarter ends December 31, 2026 | $-0.15 | −55.0% | $0 |
| Quarter after ends March 31, 2027 | $-0.20 | +39.4% | $0 |
Consensus of the analysts covering Eledon Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Eledon Pharmaceuticals stock price target?
The average 12-month target from 5 analysts is $9.00, 325.5% above the current price of $2.12 Targets range from $7.00 to $12.00.
Is Eledon Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (6 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Eledon Pharmaceuticals expected to earn?
Analysts expect EPS of $-0.89 for the fiscal year ending December 31, 2026 and $-0.76 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.